Verily-Sanofi joint venture Onduo has signed a deal with Orpyx Medical Technologies to offer the latter firm's SurroSense Rx system to select members of Onduo’s personalised diabetes management platform in 2019. " What’s the impact Onduo’s digital platform is an integrated ecosystem of software and devices designed to provide personalized diabetes management. The company said it had been working on developing its own sensor technology for more than two years and that it was now ready to introduce it.
Verily-Sanofi joint venture Onduo has signed a deal with Orpyx Medical Technologies to offer the latter firm's SurroSense Rx system to select members of Onduo’s personalised diabetes management platform in 2019. The company said it had been working on developing its own sensor technology for more than two years and that it was now ready to introduce it.